<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Abortion Drug Requires Access</title>
    <meta content="LTR003929" name="slug"/>
    <meta content="3" name="publication_day_of_month"/>
    <meta content="10" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Tuesday" name="publication_day_of_week"/>
    <meta content="Editorial Desk" name="dsk"/>
    <meta content="26" name="print_page_number"/>
    <meta content="A" name="print_section"/>
    <meta content="6" name="print_column"/>
    <meta content="Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1235787"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Abortion</classifier>
        <classifier class="indexing_service" type="descriptor">Ru-486 (Drug)</classifier>
        <person class="indexing_service">Braunstein, Richard B (Dr)</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion/Letters</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Abortion</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20001003T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9905E6DE103DF930A35753C1A9669C8B63" item-length="161" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Abortion Drug Requires Access</hl1>
      </hedline>
      <abstract>
        <p>Dr Richard B Braunstein letter holds Sept 30 editorial on access to abortion drug RU-486 is sound analysis of abortionpill's probable effect on this country's women as well as impediments that anti-choice groups will try to put in its way</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>Your Sept. 30 editorial ''Access to RU-486'' is a sound analysis of the abortion pill's probable effect on this country's women as well as the impediments that anti-choice groups will try to put in its way.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>Your Sept. 30 editorial ''Access to RU-486'' is a sound analysis of the abortion pill's probable effect on this country's women as well as the impediments that anti-choice groups will try to put in its way.</p>
        <p>The opponents claim concern for the risks that RU-486 may hold for the user. What they choose not to acknowledge is the fact that abortion in medical hands is statistically safer in terms of mortality and morbidity than delivering a baby. Only the woman, with her doctor's advice, should make that choice, and RU-486 substantially increases her options.</p>
        <p>RICHARD B. BRAUNSTEIN, M.D.  San Carlos, Calif., Sept. 30, 2000</p>
      </block>
    </body.content>
  </body>
</nitf>
